Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options

被引:20
|
作者
Di Lullo, Luca [1 ]
Ronco, Claudio [2 ]
Granata, Antonio [3 ,4 ]
Paoletti, Ernesto [5 ]
Barbera, Vincenzo [1 ]
Cozzolino, Mario [6 ]
Ravera, Maura [5 ]
Fusaro, Maria [7 ]
Bellasi, Antonio [8 ]
机构
[1] L Parodi Delfino Hosp, Dept Nephrol & Dialysis, Colleferro, Italy
[2] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy
[3] S Giovanni di Dio Hosp, Dept Nephrol & Dialysis, Agrigento, Italy
[4] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy
[5] San Martino Hosp, Dept Nephrol & Dialysis, Genoa, Italy
[6] S Paolo Hosp, Dept Hlth Sci, Milan, Italy
[7] Univ Padua, Dept Med, Padua, Italy
[8] St Anna Hosp, ASTT Lariana, Dept Nephrol & Dialysis, Como, Italy
关键词
Hyperkalemia; Chronic kidney disease; Heart failure; Renin-angiotensin-aldosterone system inhibitors; Potassium binder; CHRONIC KIDNEY-DISEASE; SODIUM ZIRCONIUM CYCLOSILICATE; HEART-FAILURE; SERUM POTASSIUM; RENAL-DISEASE; DOUBLE-BLIND; PATIROMER; OUTCOMES; ALDOSTERONE; ASSOCIATION;
D O I
10.1159/000493395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:8 / 21
页数:14
相关论文
共 50 条
  • [31] Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study
    Kanda, Eiichiro
    Morita, Naru
    Yajima, Toshitaka
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [32] Risk factors of gender for renal progression in patients with early chronic kidney disease
    Chang, Po-Ya
    Chien, Li-Nien
    Lin, Yuh-Feng
    Wu, Mai-Szu
    Chiu, Wen-Ta
    Chiou, Hung-Yi
    MEDICINE, 2016, 95 (30)
  • [33] Biochemical Risk Factors Associated With Hyperkalemia in Cirrhotic Patients
    Gurnani, Versha
    Kumar, Nomesh
    Khan, Shayan Iqbal
    Nawaz, Muhammad Umair
    Ahmed, Hassan
    Naz, Sidra
    Shah, Aresha Masood
    Jahangir, Maha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [34] A risk model for the early diagnosis of acute myocardial infarction in patients with chronic kidney disease
    Su, Xiao-Feng
    Chen, Xu
    Zhang, Tao
    Song, Jun-Mei
    Liu, Xin
    Xu, Xing-Li
    Fan, Na
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [35] Comparative risk of new-onset hyperkalemia for antihypertensive drugs in patients with diabetic nephropathy: A Bayesian network meta-analysis
    Zhu, Simin
    Li, Juan
    Zhao, Xinyuan
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (08)
  • [36] New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease
    Rastogi, Anjay
    Arman, Farid
    Alipourfetrati, Setareh
    CURRENT HYPERTENSION REPORTS, 2016, 18 (07)
  • [37] Diagnosis and Treatment in Chronic Kidney Disease and Evalution of Cardiovascular Disease and Associated Risk Factors
    Kadiroglu, Ali Kemal
    Sit, Dede
    Yilmaz, M. Emin
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2008, 17 (01): : 1 - 9
  • [38] Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor
    Ozkok, Abdullah
    Kanbay, Asiye
    Odabas, Ali Riza
    Covic, Adrian
    Kanbay, Mehmet
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2014, 36 (04) : 211 - 216
  • [39] Modern Bronchoscopic Treatment Options for Patients with Chronic Bronchitis
    Mayr, Anna Katharina
    Valipour, Arschang
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [40] The Effect of Patient Factors and Cotreatments on the Magnitude of Potassium Lowering with Insulin-Glucose Treatment in Patients with Hyperkalemia
    Lim, Andy K. H.
    Crnobrnja, Ljiljana
    Metlapalli, Manogna
    Govinna, Mauli
    Jiang, Cathy
    EPIDEMIOLOGIA, 2021, 2 (01): : 27 - 35